Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,180.6
38.9 (1.24%)

 

  • STI Straits Times Index
    3,180.6
    38.9 (1.24%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,512.9
    -2.5 (-0.16%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,315.3
    841.4 (3.30%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,411.7
    50.1 (1.49%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,782.4
    200.8 (0.73%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,120.7
    32.2 (0.53%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,159.2M
  • Value: 1,470.4M
  • Rise: 205
  • Fall: 137
  • Unch: 419

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
GKE0.153-0.008
Golden Agri-Res0.235+0.020
CapAllianz0.003-
Abundance Intl0.042-
Singtel2.280+0.050
Shen Yao0.007+0.001
RH PetroGas0.182+0.010
ISDN0.780+0.070
Sembcorp Marine0.108-0.002
Geo Energy Res0.260+0.015

World Indices

World Indices
Name Last Change
Nasdaq 14,762.6 +102.0
HSI 26,315.3 +841.4
HSCEI 9,415.7 +344.6
Jakarta 6,120.7 +32.2
Nikkei 225 27,782.4 +200.8
SSE Comp 3,411.7 +50.1
Shanghai A 3,575.8 +52.6
Shanghai B 256.1 +1.6
KOSPI 3,242.7 +5.8

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

DELCATH SYSTEMS INC DELCATH SYSTEMS
Updated on 28 Jul 2021 (End of trading day)
Last (USD): 9.870 Change: +0.900 High: 10.075 Remarks: -
Change (%): +10.03 Low: 8.800
Open 8.980 Yesterday's Close 8.969999999999999
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 43,508 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -3.29411 Trailing EPS (USD) e -3.14254 NAV (USD) b 2.7220
PE a - Trailing PE f - Price / NAV b 3.6260
Dividend (USD) d - Cash In Hand (USD) g 3.6260 Issued & Paid-up Shares c 7,349,780
Dividend Yield (%) d - Price / Cash In Hand g 2.722 Treasury Shares h -
Market Cap (M) 72.542 Enterprise Value (M) 48.682
Piotroski F Score 2 Exchange Code DCTH Par Value ( $ ) n.a.
52 Weeks Volatility (%) 71.46 Free Float (%) 98.3
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 29 Jun 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 01 May 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference DELCATH SYSTEMS INC NASDAQ 72.542 - - 3.6260 -
Industry Medical Specialties NASDAQ 3,471.654 169.324 143.661 9.8978 0.024
Local Peer INTUITIVE SURGICAL INC NASDAQ 115,482.430 108.884 71.171 10.6558 -
Local Peer IDEXX LABORATORIES INC NASDAQ 59,319.549 101.963 87.984 84.4171 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 49,212.677 27.712 107.420 14.5017 -
Local Peer DEXCOM INC NASDAQ 44,476.978 90.107 86.531 23.3696 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 29,380.176 40.379 34.460 9.2518 -
Local Peer NOVOCURE LTD NASDAQ 18,812.893 949.776 1,604.101 50.5544 -
Local Peer HOLOGIC INC NASDAQ 18,469.275 16.561 9.684 4.8675 -
Local Peer INSULET CORPORATION NASDAQ 18,670.505 2,745.693 2,097.810 31.8990 -
Local Peer MASIMO CORPORATION NASDAQ 14,571.359 60.638 63.502 10.9601 -
Local Peer ABIOMED INC NASDAQ 14,682.711 65.105 65.105 11.0423 -
Local Peer DENTSPLY SIRONA INC NASDAQ 14,225.601 - 81.803 2.8873 0.615
Local Peer BRUKER CORPORATION NASDAQ 12,344.416 78.228 60.512 12.7564 0.197
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), QUIDEL CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), ORTHO CLINICAL DIAGNOSTCS HLDGS PLC (NASDAQ), NEOGEN CORP (NASDAQ), CAREDX INC (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), INMODE LTD (NASDAQ), LIVANOVA PLC (NASDAQ), ATRICURE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), AXONICS INC (NASDAQ), HESKA CORP (NASDAQ), VERICEL CORP (NASDAQ), CYTEK BIOSCIENCES INC (NASDAQ), THE BEAUTY HEALTH COMPANY (NASDAQ), OUTSET MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), INOGEN INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), SIGHT SCIENCES INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), MESA LABORATORIES INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), TREACE MED CONCEPTS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), PULMONX CORPORATION (NASDAQ), EARGO INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), SINGULAR GENOMICS SYSTEMS INC (NASDAQ), ATRION CORP (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), BIOVENTUS INC (NASDAQ), SI BONE INC (NASDAQ), DERMTECH INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), CUTERA INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), 908 DEVICES INC (NASDAQ), CERUS CORP (NASDAQ), AXOGEN INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SURMODICS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), NYXOAH SA (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), ZYNEX INC (NASDAQ), TALIS BIOMEDICAL CORP (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), NEUROPACE INC (NASDAQ), PAVMED INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), SOLITON INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AVITA MEDICAL INC (NASDAQ), ONCOCYTE CORP (NASDAQ), SIENTRA INC (NASDAQ), IRADIMED CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), MISONIX INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CVRX INC (NASDAQ), LUCIRA HEALTH INC (NASDAQ), NEURONETICS INC (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), CYTOSORBENTS CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), QUOTIENT LTD (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PROFOUND MED CORP (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), CONFORMIS INC (NASDAQ), CORMEDIX INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), TELA BIO INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), INTRICOM CORP (NASDAQ), MYMD PHARMACEUTICALS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD (NASDAQ), TITAN MEDICAL INC (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), VENUS CONCEPT INC (NASDAQ), FONAR CORP (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), CHECK-CAP LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), IRIDEX CORP (NASDAQ), NEUROMETRIX INC (NASDAQ), LENSAR INC (NASDAQ), NEPHROS INC (NASDAQ), CELSION CORPORATION (NASDAQ), AVINGER INC (NASDAQ), BIOLASE INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), ELECTROCORE INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), NEOVASC INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), NANOVIBRONIX INC (NASDAQ), INSPIRA TECH OXY BHN LTD (NASDAQ), INSPIREMD INC (NASDAQ), DYNATRONICS CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), NUWELLIS INC (NASDAQ), RESHAPE LIFESCIENCES INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), CYANOTECH CORP (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 214,142.346 47.874 33.718 - 1.266
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 207,624.902 32.569 26.202 5.9223 0.168
Global Peer DANAHER CORP NYSE 209,087.032 59.569 59.569 5.2949 0.245
Global Peer MEDTRONIC PLC NYSE 175,405.828 48.643 48.643 3.4107 1.779
Global Peer STRYKER CORP NYSE 101,224.653 63.305 71.893 7.4970 0.875
Global Peer BECTON DICKINSON & CO NYSE 73,716.800 96.111 44.949 2.9696 1.259
Global Peer EDWARDS LIFESCIENCES CORP NYSE 68,417.368 83.091 80.396 14.6868 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 64,551.941 - 451.412 - -
Global Peer AGILENT TECHNOLOGIES INC NYSE 45,959.477 63.921 49.686 9.5550 0.480
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 41,741.654 30.848 31.159 2.9450 2.240
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), RESMED INC (NYSE), ALCON AG (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), WATERS CORP (NYSE), STERIS PLC (NYSE), BIO RAD LABORATORIES INC (NYSE), COOPER COS INC (NYSE), PERKINELMER INC (NYSE), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), MICROPORT-100 (HKEx), COCHLEAR LTD (ASX), QIAGEN NV (NYSE), PENUMBRA INC (NYSE), GLOBUS MED INC (NYSE), HILL-ROM HOLDINGS INC (NYSE), ANGELALIGN (HKEx), WEIGAO GROUP (HKEx), TOPGLOV (Bursa), Top Glove (SGX), ENVISTA HOLDINGS CORPORATION (NYSE), HARTA (Bursa), NEVRO CORP (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), CONMED CORP (NYSE), EBOS GROUP (ASX), CARDIOFLOW-B (HKEx), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), PEIJIA-B (HKEx), LIFETECH SCI (HKEx), GLAUKOS CORPORATION (NYSE), SUPERMX (Bursa), BUTTERFLY NETWORK INC (NYSE), ZYLOXTB-B (HKEx), AVANOS MEDICAL INC (NYSE), KANGJI MEDICAL (HKEx), AK MEDICAL (HKEx), NANOSONICS LIMITED (ASX), CIRC (HKEx), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), CHUNLI MEDICAL (HKEx), MODERN DENTAL (HKEx), KDL MEDICAL (HKEx), STEREOTAXIS INC (NYSE American), VAPOTHERM INC (NYSE), BASECARE-B (HKEx), MCP INCOME OPPORTUNITIES TRUST (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), YESTAR HEALTH (HKEx), Medtecs Intl (SGX), AROA BIOSURGERY LTD (ASX), INVACARE CORP (NYSE), UGHealthcare (SGX), PW MEDTECH (HKEx), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), INCANNEX HEALTHCARE LTD (ASX), SOMNOMED LIMITED (ASX), ALPHA PRO TECH (NYSE American), EMVISION MEDICAL DEVICES LTD (ASX), LUMOS DIAGNOSTICS HOLDINGS LIMITED (ASX), KELFRED (HKEx), CYCLOPHARM LIMITED (ASX), VINCENT MED (HKEx), IMPEDIMED LIMITED (ASX), MICRO-X LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), ELECTROMED INC (NYSE American), OPTISCAN IMAGING (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), CLEANSPACE HOLDINGS LTD (ASX), VOLITIONRX LIMITED (NYSE American), SDI LTD (ASX), ADVENTA (Bursa), IMAGION BIOSYSTEMS LIMITED (ASX), YUNNAN ENERGY (HKEx), RGTBHD (Bursa), MILESTONE SCIENTIFIC INC (NYSE American), RESONANCE HEALTH LTD (ASX), Biolidics (SGX), COMPUMEDICS (ASX), CARDIEX LTD (ASX), LKL (Bursa), DAXOR CORP (NYSE American), DIMERIX LTD (ASX), Yunnan Energy (SGX), NOVA EYE MEDICAL LIMITED (ASX), RESPIRI LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ADHERIUM LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX), LBT INNOVATIONS LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), LIFE HEALTHCARE (HKEx), OVENTUS MEDICAL LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE American), METALICITY LIMITED (ASX), USCOM LTD (ASX), TRUSCREEN GROUP LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), Annica (SGX), HUAKANG BIOMED (HKEx), ANALYTICA (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.280
+2.92 %
10 Days --0.020
-0.20 %
20 Days --2.780
-21.98 %
Medium Term Return 3 Months --1.930
-16.36 %
6 Months --5.880
-37.33 %
1 Year --2.670
-21.29 %
Long Term Return 2 Years --18.830
-65.61 %
3 Years --18.830
-65.61 %
5 Years --1603.630
-99.39 %
Annualised Return Annualised --
-63.92 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 8.780 - 25.180 Change From 1 Year Low +1.090 % Change From 1 Year Low (%) +12.41
Change From 1 Year High -15.310 % Change From 1 Year High (%) -60.80
2 Years Range 6.060 - 25.180 Change From 2 Years Low +3.810 % Change From 2 Years Low (%) +62.87
Change From 2 Years High -15.310 % Change From 2 Years High (%) -60.80
5 Years Range 5.250 - 2,271.500 Change From 5 Years Low +4.620 % Change From 5 Years Low (%) +88.00
Change From 5 Years High -2261.630 % Change From 5 Years High (%) -99.57
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers. It develops and commercializes CHEMOSAT and Melphalan Hydrochloride for Injection, which is a proprietary product used with the Delcath Hepatic Delivery System. The company was founded in August 1988 and is headquartered in New York, NY.

Historical Price Data

Date Open High Low Close Volume VWAP
28 Jul 2021 8.980 10.075 8.800 9.870 43,508 -
27 Jul 2021 9.100 9.140 8.900 8.970 34,883 -
26 Jul 2021 9.400 9.590 9.070 9.150 18,715 -
23 Jul 2021 9.630 9.765 9.284 9.430 40,207 -
22 Jul 2021 9.790 9.910 9.220 9.590 38,518 -
21 Jul 2021 9.640 10.120 9.597 9.840 49,169 -
20 Jul 2021 9.020 9.760 8.980 9.610 82,746 -
19 Jul 2021 9.190 9.270 8.780 8.900 119,139 -
16 Jul 2021 10.040 10.220 9.510 9.600 43,870 -
15 Jul 2021 9.980 10.250 9.750 9.890 77,301 -
14 Jul 2021 10.480 10.700 9.850 10.070 48,533 -
13 Jul 2021 11.010 11.100 10.320 10.440 76,121 -
12 Jul 2021 10.960 11.550 10.590 11.090 30,308 -
09 Jul 2021 11.300 11.379 10.800 10.930 53,714 -
08 Jul 2021 11.250 11.250 10.630 11.140 82,656 -
07 Jul 2021 12.510 12.510 11.400 11.400 78,673 -
06 Jul 2021 13.250 13.250 12.227 12.390 135,588 -
02 Jul 2021 12.830 12.959 12.200 12.650 41,167 -
01 Jul 2021 13.180 13.300 12.100 12.650 113,999 -
30 Jun 2021 12.300 13.500 11.687 12.610 166,900 -
29 Jun 2021 11.650 12.440 11.470 12.240 79,823 -
28 Jun 2021 11.670 12.250 11.185 11.530 103,933 -
Summary
Current 2 Weeks
(15 Jul 2021 to 28 Jul 2021)
9.980 10.250 8.780 9.870 548,056 -
Previous 2 Weeks
(30 Jun 2021 to 14 Jul 2021)
12.300 13.500 8.780 10.070 827,659 -
4 Weeks from
(02 Jun 2021 to 29 Jun 2021)
11.300 11.384 8.780 12.240 1,186,773 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.